{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:32:15Z","timestamp":1777041135466,"version":"3.51.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEUONC"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1093\/neuonc\/now089","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:53:52Z","timestamp":1462928032000},"page":"1390-1401","source":"Crossref","is-referenced-by-count":22,"title":["Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models"],"prefix":"10.1093","volume":"18","author":[{"given":"Kader","family":"Yagiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany T.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lopez Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry E.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan M.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"issue":"(suppl 1)","key":"2016092405321584000_18.10.1390.1","first-page":"S9","article-title":"The future of high-grade glioma: where we are and where are we going","volume":"6","author":"Le Rhun","year":"2015","journal-title":"Surg Neurol Intern"},{"key":"2016092405321584000_18.10.1390.2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.83"},{"key":"2016092405321584000_18.10.1390.3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor199"},{"key":"2016092405321584000_18.10.1390.4","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2013.51"},{"issue":"(2)","key":"2016092405321584000_18.10.1390.5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/hum.2014.100","article-title":"Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model","volume":"26","author":"Huang","year":"2015","journal-title":"Hum Gene Ther"},{"key":"2016092405321584000_18.10.1390.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.6497"},{"key":"2016092405321584000_18.10.1390.7","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2010000500020"},{"key":"2016092405321584000_18.10.1390.8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou118"},{"key":"2016092405321584000_18.10.1390.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.1932"},{"key":"2016092405321584000_18.10.1390.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.2195"},{"key":"2016092405321584000_18.10.1390.11","doi-asserted-by":"crossref","unstructured":"Wick W , Brandes A , Gorlia T . LB-05PHASE III trial exploring the combination of bevacizumab and lomustine in patients with first recurrence of a glioblastoma: the eortc 26101 trial. Neurooncol . 2015;17 (suppl 5):v1\u2013v230.","DOI":"10.1093\/neuonc\/nov306"},{"key":"2016092405321584000_18.10.1390.12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/54.1.69"},{"issue":"(2)","key":"2016092405321584000_18.10.1390.13","first-page":"460","article-title":"Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression","volume":"35","author":"Tobey","year":"1975","journal-title":"Cancer Res"},{"issue":"(3)","key":"2016092405321584000_18.10.1390.14","first-page":"773","article-title":"Intratumoral 5-fluorouracil produced by cytosine deaminase\/5-fluorocytosine gene therapy is effective for experimental human glioblastomas","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"key":"2016092405321584000_18.10.1390.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-9875-7"},{"key":"2016092405321584000_18.10.1390.16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos337"},{"issue":"(4)","key":"2016092405321584000_18.10.1390.17","first-page":"829","article-title":"Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines","volume":"15","author":"Pohl","year":"1999","journal-title":"Int J Oncol"},{"key":"2016092405321584000_18.10.1390.18","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2007.106.4.652"},{"key":"2016092405321584000_18.10.1390.19","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1980.52.3.0359"},{"issue":"(10)","key":"2016092405321584000_18.10.1390.20","first-page":"3761","article-title":"DNA damage in the intracerebral rat gliosarcoma 9L treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea","volume":"37","author":"Gutin","year":"1977","journal-title":"Cancer Res"},{"key":"2016092405321584000_18.10.1390.21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2147\/OTT.S62887","article-title":"xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies","volume":"7","author":"Martinez-Serra","year":"2014","journal-title":"Onco Targets Ther"},{"key":"2016092405321584000_18.10.1390.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2007.04.022"},{"issue":"(9)","key":"2016092405321584000_18.10.1390.23","first-page":"2373","article-title":"Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors","volume":"51","author":"Tzeng","year":"1991","journal-title":"Cancer Res"},{"key":"2016092405321584000_18.10.1390.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0295-5"},{"issue":"(1)","key":"2016092405321584000_18.10.1390.25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.4-1-45","article-title":"Long-Term survivors of childhood cancer: the late effects of therapy","volume":"4","author":"Schwartz","year":"1999","journal-title":"Oncologist"},{"key":"2016092405321584000_18.10.1390.26","doi-asserted-by":"crossref","unstructured":"Yagiz K , Rodriguez-Aguirre ME , Espinoza FL . Intravenous Delivery of Toca 511 Gene Therapy in Combination with 5-Fluorocytosine for Intratumoral Production of 5-Fluorouracil in a Colon Cancer Metastasis Model. Paper presented at: Molecular Therapy2015.","DOI":"10.1016\/S1525-0016(16)34140-5"},{"issue":"(6)","key":"2016092405321584000_18.10.1390.27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/030089160409000618","article-title":"Overdose of lomustine: report of two cases","volume":"90","author":"Buyukcelik","year":"2004","journal-title":"Tumori"},{"issue":"(2)","key":"2016092405321584000_18.10.1390.28","first-page":"174","article-title":"Nephrotoxicity of lomustine. A case report and literature review","volume":"15","author":"Ellis","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"2016092405321584000_18.10.1390.29","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900409"},{"key":"2016092405321584000_18.10.1390.30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301209"},{"key":"2016092405321584000_18.10.1390.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-005-9115-8"},{"key":"2016092405321584000_18.10.1390.32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2140"},{"key":"2016092405321584000_18.10.1390.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.2595"},{"key":"2016092405321584000_18.10.1390.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(82)80043-1"},{"key":"2016092405321584000_18.10.1390.35","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.171"},{"key":"2016092405321584000_18.10.1390.36","doi-asserted-by":"crossref","first-page":"170858","DOI":"10.1155\/2015\/170858","article-title":"Combined effects of muricid extract and 5-fluorouracil on intestinal toxicity in rats","volume":"2015","author":"Yazbeck","year":"2015","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/18\/10\/1390\/17430879\/now089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T17:31:23Z","timestamp":1600536683000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/now089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,9,24]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1093\/neuonc\/now089"],"URL":"https:\/\/doi.org\/10.1093\/neuonc\/now089","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}